Keene & Associates’s Elanco Animal Health ELAN Stock Holding History

Keene & Associates’s Portfolio ELAN Stock Details ELAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	$354K	Buy	29,230 +6,285	+27%	+$82.2K	0.28%	65
2024 Q3	$337K	Buy	22,945 +1,240	+6%	+$17.3K	0.26%	69
2024 Q2	$313K	Sell	21,705 -2,110	-9%	-$33.7K	0.26%	64
2024 Q1	$388K	Sell	23,815 -28,189	-54%	-$441K	0.29%	62
2023 Q4	$775K	Sell	52,004 -90	-0.2%	-$1.02K	0.64%	36
2023 Q3	$586K	Buy	52,094 +2,180	+4%	+$25.3K	0.47%	41
2023 Q2	$502K	Buy	49,914 +322	+0.6%	+$2.99K	0.39%	44
2023 Q1	$466K	Buy	49,592 +38,393	+343%	+$453K	0.36%	42
2022 Q4	$137K	Sell	11,199 -16,625	-60%	-$207K	0.12%	72
2022 Q3	$345K	Buy	27,824 +2,255	+9%	+$39.4K	0.32%	43
2022 Q2	$502K	Buy	25,569 +1,529	+6%	+$36.2K	0.47%	38
2022 Q1	$627K	Buy	24,040 +3,395	+16%	+$90.4K	0.51%	42
2021 Q4	$586K	Buy	+20,645	New	+$642K	0.51%	41

Other funds holding ELAN

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

SCM

Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Keene & Associates's ELAN Position: Q4 2024 in Review

Keene & Associates increased its Elanco Animal Health (ELAN) stake by 27% in Q4 2024, buying an estimated $82.2K and bringing the position to 29,230 shares worth $354K. The position accounts for 0.28% of the portfolio, ranked #65.

Keene & Associates first reported a position in ELAN in Q4 2021 and has held it in 13 quarters since. The position peaked at $775K in Q4 2023. 392 funds tracked by Wall St. Rank hold ELAN as of Q4 2024.

Keene & Associates held 29,230 shares of Elanco Animal Health worth $354K as of Q4 2024.
Keene & Associates bought 6,285 Elanco Animal Health shares in Q4 2024, an estimated $82.2K.
Elanco Animal Health made up 0.28% of Keene & Associates's portfolio in Q4 2024, its #65 holding.
Keene & Associates first reported a position in Elanco Animal Health in Q4 2021 and has held it in 13 quarters since.
Keene & Associates's Elanco Animal Health position peaked at $775K in Q4 2023.
392 funds tracked by Wall St. Rank held Elanco Animal Health as of Q4 2024.

Based on Keene & Associates's 13F filing for Q4 2024, filed 3 Feb 2025.